China Joins WHO Covax Vaccine Program

The transcript discusses China's involvement in global vaccine distribution, highlighting its strategic use of vaccines for diplomacy and soft power. It contrasts China's approach with the US, which prioritizes domestic vaccine distribution. The discussion also covers China's progress in vaccine development, including challenges due to the contained outbreak within the country, necessitating trials in other regions.

In what ways might China's vaccine initiative serve as an insurance policy for its own vaccine access?

What challenges has China encountered in conducting phase three trials for its vaccines?